Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study
In: Blood, Jg. 133 (2019-02-07), Heft 6, S. 540-549
academicJournal
Zugriff:
Titel: |
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study
|
---|---|
Autor/in / Beteiligte Person: | Kulasekararaj, Austin G. ; Hill, Anita ; Rottinghaus, Scott T. ; Langemeijer, Saskia ; Wells, Richard ; Gonzalez-Fernandez, F. Ataulfo ; Gaya, Anna ; Lee, Jong Wook ; Gutierrez, Emilio Ojeda ; Piatek, Caroline I. ; Szer, Jeff ; Risitano, Antonio ; Nakao, Shinji ; Bachman, Eric ; Shafner, Lori ; Damokosh, Andrew I. ; Ortiz, Stephan ; Röth, Alexander ; Peffault de Latour, Regis |
Zeitschrift: | Blood, Jg. 133 (2019-02-07), Heft 6, S. 540-549 |
Veröffentlichung: | 2019 |
Medientyp: | academicJournal |
ISSN: | 0006-4971 (electronic) |
DOI: | 10.1182/blood-2018-09-876805 |
Sonstiges: |
|